30

Sirio Pharma

300791 · SHE · Consumer Defensive / Packaged Foods

16.40CNY-0.39 (-2.32%)

Price History

Full chart

Market Stats

Previous Close16.79
Open16.75
Day Range16.36 – 16.82
52-Week Range15.40 – 25.97
Volume1.00M
Market Cap5.67B
P/E (TTM)42.81
Forward P/E0.00
EPS0.43
Dividend Yield0.71%
Beta0.34
50-Day Avg17.29
200-Day Avg19.59

About

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry China, the United States, Europe, and internationally. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; liquids; probiotic balls; tablet and powder products; capsules; and functional beverages for beauty and wellness, gut health, bone and joint health, immune and fertility support, cardiovascular and metabolic health, and healthy ageing. It also offers formulation; technical, and research and development support; and primary and final packaging services. Sirio Pharma Co., Ltd. was founded in 1993 and is headquartered in Shantou, China.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Peiqing Li
  • Employees2.78K
  • HeadquartersNo. 83, Taishan Road, Shantou, China, 515000, China
  • Websitehttps://www.siriopharma.com

Leadership

  • Mr. Peiqing LiGM & Chairman of the Board · b. 1965
  • Ms. Liqun ZhengDeputy GM & CFO · b. 1971
  • Ms. Qiong ChenDeputy GM & Director · b. 1966
  • Mr. Ruoyang LiuDeputy GM & Board Secretary · b. 1989
  • Ya SongAccounting Supervisor

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue553.77M698.68M778.60M824.44M786.19M1.33B1.60B1.58B2.07B2.37B2.51B3.58B4.21B4.26B
Growth (%)-+26.17%+11.44%+5.89%-4.64%+69.23%+19.91%-0.99%+30.85%+14.62%+5.84%+42.87%+17.56%+1.23%
Cost of Revenue366.83M433.96M464.15M470.28M535.31M896.36M1.05B1.07B1.41B1.60B1.74B2.50B2.89B2.96B
Gross Profit186.94M264.71M314.45M354.16M250.88M434.11M540.80M510.35M661.56M764.94M770.42M1.08B1.32B1.30B
Gross Margin33.76%37.89%40.39%42.96%31.91%32.63%33.90%32.31%32.01%32.29%30.73%30.28%31.34%30.57%
Operating Expense132.12M195.02M240.42M284.47M-682.19M308.22M312.56M358.66M345.95M475.12M505.37M802.49M992.84M974.58M
Operating Income54.82M69.69M74.04M69.69M933.07M125.89M228.24M151.69M315.61M289.81M265.06M282.02M327.01M328.52M
Operating Margin9.90%9.97%9.51%8.45%118.68%9.46%14.31%9.60%15.27%12.23%10.57%7.87%7.77%7.71%
EBITDA79.95M100.97M113.63M117.05M80.75M198.34M282.89M225.01M353.57M379.29M366.95M597.06M612.03M354.56M
EBITDA Margin14.44%14.45%14.59%14.20%10.27%14.91%17.73%14.25%17.11%16.01%14.64%16.67%14.53%8.32%
Net Income45.33M54.55M61.45M56.27M703.73M104.30M203.23M142.53M257.37M231.83M212.29M281.04M325.06M136.53M
Net Income Margin8.19%7.81%7.89%6.82%89.51%7.84%12.74%9.02%12.45%9.79%8.47%7.85%7.72%3.20%
R&D----40.85M45.51M62.06M65.78M64.71M83.19M80.72M110.49M128.76M145.94M
R&D as % of Total Revenue----5.20%3.42%3.89%4.16%3.13%3.51%3.22%3.08%3.06%3.42%
Interest Expense7.92M9.65M10.56M10.43M12.38M14.05M16.63M17.43M3.40M15.17M44.24M61.86M97.32M102.73M
Interest Expense % of Total Revenue1.43%1.38%1.36%1.26%1.57%1.06%1.04%1.10%0.16%0.64%1.76%1.73%2.31%2.41%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets429.28M522.23M545.12M694.88M1.47B1.29B1.54B2.36B2.65B3.82B4.19B5.20B5.49B5.59B
Total Liabilities261.51M318.67M406.24M453.53M1.01B707.58M759.53M414.01M466.95M1.28B1.48B2.63B2.84B2.63B
Total Equity167.77M203.56M138.88M241.35M461.94M580.20M784.05M1.95B2.18B2.54B2.70B2.39B2.51B2.94B
Cash15.50M52.75M45.13M53.05M272.67M114.82M72.37M395.40M216.70M715.54M1.50B534.49M636.03M595.14M
Total Debt118.29M119.35M158.15M256.39M391.08M372.70M430.85M99.77M34.71M874.26M936.90M1.31B1.54B-
Net Debt102.78M66.60M113.02M203.34M118.40M257.87M358.47M-295.63M-181.99M158.72M-564.70M770.71M902.79M660.65M

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow35.25M122.50M90.94M106.71M-98.26M49.35M183.46M231.60M319.57M341.38M444.86M386.08M566.97M570.18M
Investing Cash Flow-65.76M-73.70M-77.21M-86.66M381.04M71.25M-238.68M-597.87M-394.98M-735.48M283.91M-1.16B-327.98M-
Financing Cash Flow16.83M-10.74M-20.00M-13.40M-244.49M-98.58M12.52M680.88M-92.91M906.11M-77.90M-91.15M-130.84M-
Capital Expenditure65.76M62.12M68.84M160.41M72.65M159.82M239.32M166.90M223.14M524.68M293.69M451.70M412.13M441.26M
Free Cash Flow-30.51M60.38M22.10M-53.70M-170.92M-110.47M-55.87M64.71M96.43M-183.31M151.17M-65.62M154.84M128.92M
Dividends Paid19.87M10.99M57.50M138.12M266.35M225.30M44.26M14.27M25.86M72.53M76.09M83.83M219.63M183.03M
FCF to OCF-86.57%49.29%24.30%-50.32%173.94%-223.84%-30.45%27.94%30.17%-53.70%33.98%-17.00%27.31%22.61%
Dividend Paid to FCF-65.12%18.21%260.18%-257.19%-155.84%-203.95%-79.21%22.05%26.82%-39.57%50.33%-127.75%141.84%141.97%

Earnings

Report DateSep 30, 2019Dec 31, 2019Apr 28, 2020Aug 25, 2020Oct 28, 2020Dec 31, 2020Apr 26, 2021Aug 25, 2021Oct 27, 2021Dec 31, 2021Apr 12, 2022Aug 25, 2022Oct 25, 2022Dec 31, 2022Apr 27, 2023Aug 24, 2023Oct 25, 2023Apr 21, 2024Aug 11, 2024Oct 23, 2024Apr 23, 2025Aug 26, 2025Oct 29, 2025Apr 24, 2026Aug 31, 2026
EPS Estimate-------------------------
EPS Actual0.100.080.280.410.340.230.320.490.300.100.090.500.360.200.220.400.470.530.510.370.360.300.320.160.33
Surprise-------------------------
Timing--After-hoursPre-marketAfter-hours-Pre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market----

Key Statistics & Ratios

Market Cap5.67B
Enterprise Value6.54B
Trailing P/E42.81
Forward P/E0.00
Price / Sales1.33
Price / Book1.80
EPS0.43
Book Value10.31
Revenue (TTM)4.27B
Gross Profit (TTM)1.25B
EBITDA415.64M
Profit Margin3.00%
Operating Margin12.14%
Return on Equity0.93%
Return on Assets2.52%
Shares Outstanding308.23M
Shares Float107.88M
Beta0.34
Dividend Yield0.71%
Dividend Rate0.13
Payout Ratio15.87%

Dividends

20261×
0.13Jun 5, 2026
20251×
0.50May 27, 2025
20241×
0.85Jun 21, 2024
20231×
0.21Jun 7, 2023
20221×
0.24May 23, 2022
20211×
0.24Jun 8, 2021
20201×
0.08May 28, 2020

Stock Splits

  • May 27, 20251.3:1
  • Jun 21, 20241.3:1
  • Jun 8, 20211.5:1
  • May 28, 20201.5:1